Drug
Mercaptamine
Mercaptamine: highest development phase Phase 3, developed by Recordati. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Recordati
Trials
| Drug | Phase | Indication |
|---|---|---|
| Mercaptamine NCT04125927 | Phase 3 | Cystinosis |
Latest
No recent events.
Follow Mercaptamine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.